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ABSTRACT Univalent antibody fragments prepared from a rabbit antiserum raised against 
whole human platelets completely inhibited adhesion of platelets to immobilized trimeric 
collagen in a defined, Mg2+-dependent, adhesion assay. An octylglucoside xtract of whole 
platelets completely neutralized this antibody, and all neutralizing activity bound to immobi- 
lized wheat germ agglutinin. Further fractionation on concanavalin A gave rise to subfractions 
that each neutralized only partially at saturation, when tested against antibody concentrations 
that inhibit 50% of platelet-collagen adhesion. When tested against higher antibody concen- 
trations that completely inhibited adhesion, each subfraction had no detectable neutralizing 
effect, although the combined subfractions neutralized completely. This and other evidence 
suggests that more than one platelet entity participates in platelet-collagen adhesion. Although 
distinct, they appear to play interdependent roles in a single adhesion process. 
Considerable vidence is accumulating that a restricted num- 
ber of surface molecules are involved in cell adhesion. The 
most extensively studied cell adhesion molecule (CAM), l N- 
CAM (l), is a large glycoprotein originally purified from chick 
neural retinal cells. It apparently mediates adhesion by direct 
association of N-CAM molecules on adjacent cells (1). A 
glycoprotein has also been implicated in adhesion in the 
cellular slime mold Dictyostelium discoideum, but its role in 
the adhesion process is unclear (2, 3). 
The approach used to identify these CAMs has been largely 
immunological. Rabbits were immunized with a crude mem- 
brane fraction, and univalent fragments of the immunoglob- 
ulins that were raised were used to inhibit cell-cell adhesion 
in an in vitro assay. In both D. discoideum and chick neural 
retina, the antibody preparation blocked adhesion completely; 
and, as might be expected, crude extracts of the antigenic 
mixture used for immunization eutralized the antibodies. In 
both cases, a single glycoprotein was isolated that could com- 
pletely neutralize the antibody effects. This raised the possi- 
bility that in each system there might be only one crucial 
Abbreviations u ed in this paper." C~, extract fraction that specifically 
bound to a concanavalin A column; Cn, extract fraction that flowed 
through a concanavalin A column; CAM, cell adhesion molecule; 
W~, extract fraction that specifically bound to a wheat germ lectin 
column; Wa, extract fraction that flowed through awheat germ lectin 
column. 
CAM, although others might still exist that were not immu- 
nogenic in the injected animals. 
Another experimental system under intensive investigation 
is the adhesion of human platelets to collagen (4, 5), which is 
an early step in hemostasis. This system is especially attractive 
in that platelets are specialized for adhesion. Platelet-collagen 
adhesion is also of great clinical significance in thrombotic 
and bleeding disorders. Early methods of quantifying this 
adhesion by observing the association of platelets with sub- 
endothelial collagen in blood vessels (6, 7) have been gradually 
supplemented by more defined assays (5, 8-11). Immunolog- 
ical techniques have been used in several attempts to identify 
molecules involved in platelet-platelet aggregation (12, 13) 
and adhesion (14, 15), but results in various adhesion systems 
have differed, in part because the assays used did not measure 
a well-characterized a hesion reaction. 
Recently, we described a quantitative assay of platelet adhe- 
sion to purified type 1 trimeric collagen covalently linked to 
plastic coverslips (10) under well-defined experimental con- 
ditions. Adhesion in this assay required a native collagen 
structure and was absolutely dependent on Mg 2*. This assay 
provided an opportunity for identification of the molecular 
basis of this adhesion. We show here that, as expected, an 
antiserum raised against human platelets completely inhibited 
platelet-collagen adhesion in our assay, and that these effects 
were neutralized by platelet extracts. However, in contrast 
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with work with D. discoideum (2, 3) or neural retina (1), 
saturating concentrations of subfractions of the platelet extract 
could not completely inhibit platelet-collagen adhesion, rais- 
ing the possibility that more than one entity is directly in- 
volved in adhesion in this system. In this article, we describe 
the results with a rabbit antiserum that led to this conclusion. 
In the subsequent article (16), we describe work that uses a 
monoclonal antibody and has identified one of the partici- 
pating molecules. 
MATERIALS AND METHODS 
Platelet Adhesion Assay 
The adhesion of gel-filtered human platelcts to trimeric ollagen immobilized 
on plastic coverslips was assayed as described previously (10). Briefly, ~Cr- 
labeled platelets were prepared and separated from plasma proteins by gel 
filtration (17) in modified Tyrode's buffer, pH 7.4, containing 1 mg/ml glucose 
and 2 mg/ml bovine serum albumin. Type I collagen trimers, derived from 
lathyritic hick skin (18), were covalently coupled to plastic coverslips using a 
carbodiimide reagent. The coverslips were placed in Linbro wells (Flow Labo- 
ratories, Inc., McLean, VA) and covered with 0.3 ml of Tyrode's buffer 
containing labeled platelets. The wells were incubated for l0 rain at 37°C on a 
gyratory shaker and washed. Adhesion, determined as 5tCr bound to coverslips, 
reached saturation within 20 rain, was Mg 2÷ dependent, and specific for collagen 
trimers or fibrils (10). 
Preparation of Adhesion-blocking Antiserum 
Rabbit antiserum was raised by immunization with whole human platelets 
that were prepared by gel filtration as described previously (10), except hat 
bovine serum albumin was omitted. Platelets prepared by this method con- 
tained <0.1% plasma proteins (flbrinogen or fibronectin) by radioimmunoassay 
and < 1% lymphocyte contamination. The rabbit was injected with 109 platelets 
in complete Freund's adjuvant and was initially boosted at~er 28 d with l08 
platelets in incomplete Freund's adjuvant. Repeated boosts were made at 
bimonthly intervals. Sera were collected 5, 7, and 9 d after the third and 
subsequent boosts and pooled, and IgG was prepared by affinity chromatogra- 
phy on a column of protein A-agarose (Pharmacia Fine Chemicals, Piscataway, 
NJ). The column was equilibrated in 75 mM Na-K phosphate, 0.15 M NaC1, 
pH 7.2. IgG was eluted with l M acetic acid, neutralized with solid Tris, and 
dialyzed into l0 mM Na phosphate, pH 7.3, 0.15 M NaC1, l mM EDTA, and 
5 mM ~-mereaptoethanol. 
To prepare Fab, mercuripapain (Sigma Chemical Co., St. Louis, MO) in 
70% ethanol was added to the lgG preparation at 20 ~1 per l0 ml oflgG (10 
mg/ml) and digestion was carried out at 37°C for l h (19). Papain was 
inactivated by addition of iodoacetamide to30 mM for 15 min at 37°C. After 
dialysis, Fab fragments were separated from Fc fragments by applying the digest 
to a second column of protein A-agarose. The flow-through fraction, containing 
Fab, was collected. Purity was checked by gel electrophoresis in SDS. 
1251-Fab Binding to Intact Platelets 
Fab was labeled with ~2~I, and its binding to platelets was determined at a 
series of concentrations e sentially as described by Pidard ct al. (20) except 
platelets were prepared by gel filtration as in the adhesion assay. 
Antisera against Fibronectin, Fibrinogen, and 
Factor VIII/von Willebrand Factor 
High-titer abbit antisera gainst human fibronectin and human fibrinogen 
were obtained from Calbiochem-Behring Corp. (La Jolla, CA). The antisera 
gave strong reactions on immunodiffusion with purified antigens. Rabbit 
antiserum against Factor VIII/von Willebrand factor was the gift of Dr. C. 
Hougie, University of California, San Diego. Fab fragments of IgG from these 
antisera were prepared as described above. 
Preparation of Outdated Platelet Extracts 
Outdated human platelet packs were obtained from the Veterans Adminis- 
tration Hospital Blood Bank, La Jolla, and the San Diego Blood Bank. Red 
blood cell contamination was reduced by repeatedly centrifuging at 500 g for 2 
min in a Sorvall GS-4 rotor (DuPont Instruments, Sorvall Biomedical Div., 
Newtown, CT) equilibrated at 10°C, and discarding the pellet. Platelets were 
pelleted by centrifugation at3,000 g for 15 min, resuspended in Tris saline (15 
mM Tfis-HCI, pH 7.4, 126 mM NaCI, 5.4 mM KCI, 5 x 10 -5 M CaCI2, I mM 
MgCI2, 0.1% glucose) and washed three to four times, until the supernatant did 
not contain appreciable protein, as measured colorimetrically (21). Platelets 
were then extracted by one of the following methods: 
FREEZE-THAW EXTRACTION OF INTACT PLATELETS:  P la te le ts  
were resuspended in Tris saline without EDTA, and the platelct suspension 
was frozen and thawed three times (22). Solubilized material was collected by 
centrifugation at 100,000 g for 1 h at 4°C. The supernatant was collected and 
used in subsequent fractionations. 
OCTYLGLUCOSIDE EXTRACTION OF INTACT PLATELETS~ 
Platelets were resuspended in Tris saline containing 1% octylglucoside and 2 
#g/ml phenylmcthylsulfonyl fluoride, and were incubated for 1 h at room 
temperature on a shaker. Centrifugation was performed as above. To test for 
neutralizing activity of the supernatant in the adhesion assay, octylglucoside 
was removed by exhaustive dialysis against Tris saline, pH 7.4. The dialyzate 
was then clarified by centrifugation at 10,000 g in a Sorvall centrifuge. 
CHYMOTRYPS IN  TREATMENT OF  INTACT PLATELETS:  The 
platelet suspension was incubated with 0.4 U/ml insolubilized a-chymotrypsin 
(Sigma Chemical Co.) for 2 h at room temperature on a shaker. Platelcts and 
enzyme-derivatized beads were removed by cent~ifugation at 750 g. Phenyl- 
methylsulfonyl fluoride was added to neutralize any residual protease activity, 
and the extract was clarified at 100,000 gas described above. 
Assay of Antibody Effects on Adhesion and 
Their Neutralization 
Antibody effects on platelct-collagen adhesion were determined by prein- 
cubating the platelets in assay medium containing aseries of concentrations of
immune Fab for l0 min at 37°C and then performing the adhesion assay over 
a 10-min period. To test platelet extracts for neutralization of the effects of 
immune Fab on platelet-collagen adhesion, a series of concentrations were 
reacted with antibody that was at a concentration that inhibited -50% of 
platelet-collagen adhesion. In general, antiplatelet Fab, at 15 ug/ml, was 
preincubated with serial dilutions of platelet extract for 30 min at 37°C. 5~Cr- 
labeled human platelets were then added and the tubes incubated for l0 min 
in a 37°C water bath. Aliquots of 0.3 ml were added to triplicate Linbro wells 
containing collagen-derivatized coverslips. Platelet adhesion was assayed over 
a 10-min period as described and quantified by measuring 5~Cr bound to the 
coverslip. Neutralization of adhesion-blocking antibodies was calculated as 
described by Brackenbury et al. (23) for each dilution of an extract: % neutral- 
ization = % adhesion (Fab + extract) - % adhesion (Fab alone)/% adhesion 
(extract alone) - % adhesion (Fab alone) x 100. One unit of neutralizing 
activity was defined as that amount hat gave 50% neutralization of the 
adhesion-blocking antibody under defined conditions. It was estimated by 
plotting the log of extract protein concentration against he percent neutrali- 
zation for serial assay points and fitting a line by the least-squares method (24). 
Specific activity was obtained by dividing activity, in units per milliliter, by the 
extract protein concentration (21), in milligrams per milliliter. 
Estimation of Platelet Lysis 
Because apparent inhibition of adhesion could result from platelet lysis 
during the assay, with release of 5JCr, we evaluated lysis at the end of the assay 
incubation. The supernatant containing unbound platelets and any free 5~Cr 
was collected and lightly fixed with 0.5% paraformaldehyde in 0.03 M Na 
phosphate buffer, pH 7.4 (17) for l0 min. An aliquot was then filtered over a 
0.2-#m filter (Millipore Corp., Medford, MA), and free ~Cr in the filtrate was 
determined. This was compared to total 5~Cr in an unfiltered aliquot. Under 
standard assay conditions, lysis estimated by this method was 0.3% or less, and 
was not affected by addition of immune Fab. 
Fractionation of Platelet Extracts on 
Lectin Columns 
The platelet extract was applied to a 3-ml column of wheat germ agglutinin- 
agarose (Vector Labs, Burlingame, CA), equilibrated in 0.05 M Tris-HCl, pH 
7.4, containing 0.15 M NaCl. After washing in this buffer, specific elution was 
carried out with 0.1 M N-acetyl-o-glucosamine  this buffer. The fraction 
eluted from the wheat germ column W~, was dialyzed into 0.05 M Tris-HCl, 
pH 8, containing 0.15 M NaCl, 1 mM CaCl2, I mM MgCl2, and was chromat- 
ographed on a 2-ml column ofconcanavalin A-agarose (E-Y Laboratories, San 
Mateo, CA). The flow-through (W~Cn) was saved, and this column was eluted 
with 0. l M a-methyl mannoside in the same buffer to give rise to the fraction 
W~C~. All fractions were dialyzed, lyophilized, and resuspended in Tris saline 
to assay neutralizing activity. 
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Preparation of Columns of Partially Purified 
Platelet Extract, and Partially Purified 
Antiplatelet IgG 
To partially purify the components of antiplatelet IgG that bound to entities 
that influenced platelet-collagen adhesion, we prepared a fraction enriched in 
platelet proteins that did not neutralize the adhesion-blocking activity of the 
antiserum and used this to adsorb irrelevant antiplatelet antibodies. To this 
end, an aliquot of an octylglucoside extract of whole platelets was repeatedly 
passed through columns of wheat germ agglutinin-agarose, and the final flow- 
through fraction, Wa, was collected. An aliquot of Wa containing ~20 mg of 
protein was coupled to cyanogen bromide-activated Sepharose (Pharmacia Fine 
Chemicals) at 4"C (25). The gel was postincubated with 1 M ethanolamine, pH 
9, to block unreacted residues. Antiplatelet IgG was then reacted with this 
column by circulating l0 mg IgG in phosphate-buffered saline, pH 7.2, over 
Wa agarose for 24 h at 4"C (26). The flow-through fraction, enriched in 
antibodies that blocked platelet-collagen adhesion, was collected, coupled to 
cyanogen bromide-activated Sepharose, and used to purify the platelet antigens 
with which it reacted. To re~over the antibodies that bound to the Wa agarose 
column, it was washed (26) and specifically eluted with 0.2 M diethylamine, 
pHI  1.5. The IgG fractions that flowed through and bound to the Wft agarose 
were digested to Fab fragments, as above, to assess their binding to platelets 
and their effect on platelet-collagen adhesion. 
PAGE 
Samples were solubilized by boiling for 10 rain in 0.2 M Tris-HCl, pH 6.8, 
containing 2% SDS, 5% ~-mereaptoethanol, and10% glycerol and electropho- 
resed in 7.5% polyacrylamide slab gels in 0.1% SDS in 0.1 M Tris-glycine 
buffer, pH 8.2. 
Prestained standards of Mr 200,000, 92,000, 66,000, 43,000, and 26,000 
(Bethesda Research Laboratories, Gaithersburg, MD) were run in parallel lanes. 
Proteins were localized by silver staining (27). In some experiments in which 
neutralizing activity was studied, unfixed gels were sliced into appropriate zones 
and protein eluted by overnight incubation in SDS-containing buffer, and freed 
of SDS by addition of acetone as described by Hager and Burgess (28). Bovine 
serum albumin (radioimmunoassay grade, Sigma Chemical Co.), 0.1 mg/ml, 
was used as a carrier protein. The eluted protein in each fraction was resolubil- 
ized in 40 ul of 6 M guanidine hydrochloride, diluted 1:50 with Tris saline, and 
dialyzed extensively against Tris saline. Serial dilutions were tested in the 
platelet-collagen adhesion assay for antibody neutralizing activity. 
RESULTS 
Fab prepared from antiplatelet antiserum completely blocked 
platelet-collagen adhesion in a dose-dependent manner (Fig. 
1 ). Preimmune Fab had no effect (Fig. 1). Fab directed against 
fibronectin, fibrinogen, or Factor VIII/von Willebrand's fac- 
tor, implicated in other platelet functions also had no detect- 
able effect on our assay, even at 10- to 20-fold higher concen- 
trations. 
To determine the nature of the materials with which the 
antibody reacted, we extracted the platelet constituents in 
three ways--by freezing and thawing, by treatment with the 
nonionic detergent octylglucoside, or by treating the surface 
of the platelets with a protease, a-chymotrypsin. Each of these 
extracts could completely neutralize the adhesion-blocking 
Fab, at the appropriate concentration which, with the octyl- 
glucoside xtract, was ~350 ~g/ml (Fig. 2). The octylglucoside 
extract seemed preferable to the others as the starting material 
for further purification inasmuch as the freeze-thaw extract 
had a lower specific activity, and the a-chymotrypsin extract 
had a lower total yield (Table I). The latter also seemed 
undesirable because the antigen it contained might be a 
proteolytic fragment rather than an intact molecule. The 
freeze-thaw procedure may also activate proteases and give 
rise to cleaved platelet glycoproteins (29), notably the mem- 
brane glycoprotein, glycoprotein lb. 
Fractionation was then attempted by affinity chromatog- 
raphy on wheat germ lectin-agarose. The neutralizing activity 
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FIGURE 1 Effect of normal (O; preimmune) and antiplatelet rabbit 
Fab (e) on platelet-collagen adhesion. Fab was preincubated with 
S~Cr-labeled human platelets for 10 min at 37°C and the adhesion 
of the platelets to immobilized trimeric collagen was determined as 
described in Materials and Methods. Each point represents the 
mean + SE of triplicate determinations. 
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FIGURE 2 Neutralization of adhesion-blocking Fab by platelet ex- 
tract. Dilutions of a dialyzed octylglucoside xtract of human plate- 
lets were preincubated with antiplatelet Fab as described in Mate- 
rials and Methods, and the effects of the mixture on platelet- 
collagen adhesion was determined. Results are mean + SE of 
triplicate determinations. Parallel samples were incubated with 
preimmune Fab and octylglucoside xtract, and showed that adhe- 
sion was not directly affected by the extract. 
in both the octylglucoside extract and the freeze-thaw extract 
bound virtually completely to this column and could be eluted 
with N-acetyl-D-glucosamine (Table II). With both extracts, 
the small amount of neutralizing activity that flowed through 
the column was completely bound when once more applied 
to the column. The specific activity of the material purified 
from the octylglucoside extract was ~30-fold greater than that 
of the initial extract and that from the freeze-thaw extract was 
-20-fold greater. 
We then sought o subfractionate he wheat germ bound 
neutralizing material (designated W~) derived from the oc- 
tylglucoside extract, by affinity chromatography on concana- 
valin A-agarose. Some of the neutralizing activity flowed 
through the concanavalin A column (designated W~Cn) and 
could not bind even with repeated passage. Another fraction 
TABLE I 
Extraction of Antibody-neutralizing Activity from Whole 
Platelets 
Protein Specific 
Extraction method extracted" activity 
mg Ulmg protein 
Freeze-thaw I. 12 5.2 
Octylglucoside 0.49 9.6 
cz-Chymotrypsin 0.I I 28.8 
Outdated human platelets were extracted and neutralizing activity was 
calculated, as described in Materials and Methods. 
* Yield per 100 ml of blood. Starting material consisted of outdated human 
platelet packs. 
TABLE II 
Fractionation of Neutralizing Activity on Wheat Germ Lectin- 
Agarose 
Protein Neutral- 
re- izing Specific 
Fraction covered activity activity 
% of applied % of ap- Ulmg protein plied 
1% Octylglucoside extract 
Flow-through fraction 70 3 0.4 
Bound and eluted fraction 5 89 291 
Freeze-thaw extract 
Flow-through fraction 72 10 0.7 
Bound and eluted fraction 4.3 82 99.2 
Outdated human platelets were extracted as described, and fractionated on 
wheat germ lectin-agarose. Neutralizing activity was calculated as described 
in Materials and Methods. 
bound to concanavalin A (designated WmC~) and was eluted 
with a-methylmannoside. To our surprise, neither fraction 
was capable of completely neutralizing the Fab, even at high 
concentrations (Fig. 3), although the starting material that 
had been eluted from the wheat germ lectin column neutral- 
ized completely. This was not due to protein losses on the 
column, because subsequent elution at low pH or with SDS 
did not release neutralizing activity. We consistently found 
that W~Ca was more potent than W~C~. Under standard 
conditions, in which neutralization was assayed at a Fab 
concentration that blocked 50% ofplatelet-coUagen adhesion, 
the former fraction neutralized up to -58% of the Fab and 
the latter up to -25% (Fig. 3). This was the maximum percent 
neutralization achieved with each fraction, and the addition 
of larger amounts of the fraction produced no further neu- 
tralization (Fig. 3). 
Because ach of these fractions only neutralized partially 
under standard conditions (Fab at a concentration that inhib- 
its 50% of the platelet-collagen adhesion), we analyzed the 
relative potency of the two subfractions and that of W~ over 
a wide range of Fab concentration. In each experiment, a Fab 
concentration was chosen that inhibited platelet-collagen 
adhesion between 40-100% based on dose-response curves 
prepared previously, and a series of concentrations of the 
fraction of interest were tested for neutralizing activity. Max- 
imal neutralization was determined as in Fig. 3. We found 
that W~ could, at an appropriate concentration, completely 
neutralize the Fab, irrespective of the degree of inhibition of 
adhesion by Fab (Fig. 4). In contrast, the two subfractions, 
each of which partially neutralized at Fab concentrations that 
inhibited platelet-collagen adhesion in the 50% range, had 
60 
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FIGURE 3 Asymptotic neutralization of adhesion-blocking Fab by 
subfractions of a platelet extract. The Wbd fraction of the platelet 
octylglucoside extract was subfractionated on a concanavalin A-  
agarose column and the neutralizing effects of a series of concen- 
trations of the two subfractions, WbdC~ (@) and WudCbd (O), were 
determined. Results are.the mean + SE of these determinations. 
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PERCENT INHIBITION OF AOHESION BY Fab 
Maximum neutralizing activity of fractions of a platelet 
extract as a function of inhibition of platelet-collagen adhesion by 
a series of dilutions of antiplatelet Fab. The fractions Wud, WbdCbd, 
and Wt~l::~ were prepared from an octylglucoside xtract of human 
platelets by lectin-affinity chromatography. A recombined fraction 
containing equal amounts of WbaC~ and WbaCff was also tested. 
Maximum neutralization of Fab at each dose of Fab was determined 
as in Fig. 3. 
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no significant neutralizing activity when tested at Fab concen- 
trations that inhibited close to 100% (Fig. 4). However, a 
mixture of the two fractions could, like the parent fraction, 
neutralize totally, even at Fab concentrations that inhibited 
platelet-collagen adhesion very extensively (Fig. 4). The im- 
plications of these findings will be considered later. 
Because WbdCn was the more potent subfraction, we further 
fractionated it by PAGE in SDS. The fractions were eluted 
from the gel and their neutralizing activity was determined 
under standard conditions in which Fab concentrations that 
inhibited 50% of platelet-collagen adhesion were employed. 
Two active fractions were resolved by this procedure. One 
with Mr ~ 90,000-100,000 produced maximum neutraliza- 
tion of ~40% (Table III). Another with Mr ~ 110,000-130,000 
produced maximal neutralization i the range of 20%. This 
latter fraction was initially isolated from two slices of the gel 
(Table lll), but probably represents a single material that runs 
in both fractions, inasmuch as combining the contents of the 
two fractions gave no greater maximum neutralization than 
was observed with each alone. This electrophoretic procedure 
apparently resolves two antigenically distinct entities in the 
W~CE, fraction, so that together with WbdC~, three distinct 
neutralizing fractions apparently exist. Their relationship will 
be considered later. 
Electrophoretic analysis of W~, W~CB, and WbdC~ by 
PAGE in SDS under reducing conditions revealed many 
protein bands that reacted with a silver stain (not shown). 
Because all these fractions were so impure, we turned to an 
alternative purification approach, by taking advantage of the 
fact that the portion of the octylglucoside extract hat failed 
to bind to a wheat germ lectin column (Wa) had no detectable 
neutralizing activity. We, therefore, coupled WE, to agarose 
and exhaustively adsorbed an IgG fraction prepared from our 
crude antiserum on this column. Unbound IgG retained 
adhesion-blocking activity, but many other antiplatelet anti- 
bodies were removed by the column. We then used the IgG 
preparation enriched in neutralizing activity as an affinity 
adsorbant by covalently linking it to agarose. Extract constit- 
uents that had neutralizing activity should bind to this col- 
umn, although many other platelet constituents might well 
also bind. 
The fraction of Wbd that bound to this column and was 
specifically eluted at pH 11.5 contained only three major 
protein bands upon PAGE (Fig. 5). It will be referred to as 
"enriched neutralizing antigen." The very prominent band 
with Mr ~ 125,000 (Fig. 5, arrow) migrated exactly with a 
purified preparation ofplatelet glycoprotein IIb and the prom- 
inent band below it with Mr ~ i00,000 co-migrated with 
platelet glycoprotein IIIa. The enriched neutralizing a tigens 
neutralized antiplatelet Fab effects on platelet-collagen adhe- 
sion in a dose-dependent manner up to a maximum of ~50% 
inhibition (Fig. 6). 
Given the fact that none of the subfractions prepared from 
W~ neutralize Fab completely, it is difficult to compare 
formally their relative potencies and specific activities with 
each other or with the starting fraction, Who. The data are 
summarized in Table IV. Here we show maximum neutrali- 
zation achieved with each subfraction under standard assay 
conditions (Fab concentration that inhibits 50% of platelet- 
collagen adhesion), and the protein concentration of each 
subfraction required to produce half the maximum neutrali- 
zation achievable with that fraction. Based on these compar- 
isons, it appears that the enriched neutralizing fraction is 
relatively potent, although it is clearly not capable of neutral- 
izing antibody completely. It is likely that it is enriched in at 
least one relevant molecule and, based on work with mono- 
clonal antibodies reported in the subsequent article (16), the 
TABLE III 
Fractionation of Antibody-neutralizing Activity by PAGE in SDS 
Maximum neutrali- 
zation observed 
Eluted zone Mean _+ SE 
Dye front-90 1 + 5 
90-100 40 +__ 17 
100-110 6 + 10 
110-120 19 + 3 
120-130 23 + 9 
130-140 0 +_ 5 
140-150 -10  _+ 14 
150-160 -15  _+ 8 
160-170 -15  + 16 
170-top of gel -1 -4- 10 
Starting material: 
W~Cf, 58 _+ 8 
An octylglucoside xtract of whole platelets was reacted with a wheat germ 
lectin-agarose column and the bound material that had been eluted with N- 
acetyl-glucosamine was passed through a concanavalin A-agarose column. 
This material (W~Cf,) was subjected to slab gel electrophoresis and the gel 
was cut into zones and eluted, all as described in Materials and Methods. 
The zone dye front-90 includes all material between the dye front and 
apparent Mr -90,000; the zone 90-100 includes all material with apparent 
M, ~90,000-100,000, etc. The apparent M,s are all based on migration of 
prestained standards run in parallel lanes of the slab gel. Maximum neutrali- 
zation was measured as in Fig. 3. 
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FIGURE 5 PAGE of enriched neutralizing antigens. Electrophoresis 
was performed as described in Materials and Methods. The gel was 
stained with silver nitrate (27). Migration of molecular weight stand- 
ards with Mr ~ 200,000, 93,000, 68,000, 43,000, and 26,000 is 
indicated. The dye front was slightly below the standard with Mr 
~26,000. The arrow indicates the migration of platelet glycoprotein 
lib, determined by electrophoresis of a preparation (the kind gift of 
Dr. E. Plow, Scripps Clinic and Research Foundation, La Jolla, CA) 
enriched in this protein on a parallel lane of the slab gel. 
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FIGURE 6 Neutralization of antiplatelet Fab by enriched neutral- 
izing antigens. Enriched neutralizing antigens were prepared as 
described in the text, dialyzed into modified Tyrode's buffer, pH 
7.4, and tested in the adhesion assay against antiplatelet Fab, as 
described in Materials and Methods. Each data point was assayed 
in triplicate and is expressed as mean _+ SE. 
molecule with Mr - 125,000, which appears to be glycoprotein 
IIb (30), probably contributes to the neutralizing activity of 
this fraction. 
We also used the antibody that bound to the Wa fraction 
in another way. Because it had no effect on platelet-collagen 
adhesion but bound many platelet antigens, we could use it 
to assess the amount of "nonspecific" Fab that can bind to a 
platelet without affecting its adhesion to collagen. |25I-labeled 
Fab prepared from this fraction bound extensively toplatelets, 
saturating at -2  x l06 Fab molecules/platelet (data not 
shown). Under these conditions, platelet-collagen adhesion 
was normal. In contrast, binding a comparable number of 
Fab molecules of an active preparation i hibited adhesion by 
at least 50%. 
DISCUSSION 
Univalent antibody fragments prepared from a rabbit anti- 
serum raised against whole human platelets completely 
blocked platelet-collagen adhesion in a quantitative assay. In 
contrast, univalent antibody fragments directed against fibro- 
nectin, fibrinogen, and Factor VIII/von Willebrand's factor 
had no effect upon platelet-collagen adhesion in our assay, 
even at concentrations 50-100 times greater than the effective 
dose for antiplatelet antibody. Thus, although these glycopro- 
teins play important roles in platelet aggregation (12, 14, 31, 
32) and antifibronectin (15) or anti-Factor VIII/von Wille- 
brand's factor (8, 9, 32) have been reported to influence 
platelet behavior in other assays, they do not appear to be 
required in our assay in which platelet aggregation is mini- 
mized. 
As in other cell adhesion systems, a crude extract of platelets 
completely neutralized the adhesion-blocking activity of our 
crude antiserum. In other adhesion systems (1, 2, 33-36), a 
single antigenic substance was identified as a CAM, and could 
completely neutralize the antiserum. What is remarkable 
about he present experiments is that subfractions ofthe crude 
extract contained activity that only partially neutralized the 
adhesion-blocking antibodies, even at saturating conditions. 
The partial neutralizing effects of these subfractions were 
highly dependent on the concentration of Fab used in the 
adhesion assay. At relatively low Fab concentrations that 
inhibited ~50% of platelet--collagen adhesion, subfraction 
W~Cn neutralized up to 60% of the adhesion-blocking activity 
of the Fab, and subfraction W~C~ neutralized up to ~25%. 
These levels of neutralization were maximal, in that adding 
increasing amounts of either neutralizing fraction to a con- 
stant amount of Fab did not produce further neutralization. 
At high Fab concentrations that inhibited 80-90% ofplatelet- 
collagen adhesion, neither subfraction had a statistically sig- 
nificant effect on platelet-collagen adhesion, even if assayed 
at high concentrations. In striking contrast, a mixture of these 
two subfractions or the parent fraction, W~, could totally 
neutralize Fab at this concentration. 
These findings indicate that the W~Cn and Wb~C~ contain 
immunologically distinct entities, each capable of neutralizing 
a different subpopulation of adhesion-blocking Fab. Each 
subpopulation of Fab is apparently capable of completely 
inhibiting platelet-collagen adhesion inasmuch as complete 
neutralization ofone subpopulation athigh Fab concentration 
has no effect on the ability of the other, unneutralized Fab 
subpopulation to inhibit all platelet--collagen adhesion. 
The dependence of the neutralizing effect of the different 
subfractions on the Fab concentration suggests that all of the 
active molecules detected here function in a single, dependent 
pathway leading to platelet-collagen adhesion, rather than 
mediating parallel, independent types of adhesion. If the two 
fractions did represent entities that mediated independent 
types of adhesion, each should neutralize the complex Fab 
mixture up to the same saturation level irrespective of the 
Fab concentration used, provided enough is added to bind all 
the Fab that reacts with it. Yet, the data indicate that even 
high concentrations of either W~Cn or W~C~ are completely 
unable to neutralize high concentrations of the complete Fab. 
This is consistent with the idea that molecules contained in- 
W~Cn and WbdC~ participate in a dependent adhesion path- 
way rather than in independent ones. If enough Fab is added 
to fully block either the relevant components of W~Cn or of 
W~C~ on the platelet, complete inhibition of adhesion re- 
sults. Neutralizing the Fab directed against one component 
does not restore adhesion as long as the other component 
remains blocked. 
TABLE IV 
Comparisons of the Activity of Various Neutralizing Fractions 
Fraction 
Protein re- Protein re- 
quired for quired for 
Maximum half-maxi- maximum 
neutraliza- mum neu- neutraliza- 
tion tralization tion 
~glml 
Octylglucoside xtract 100 104 300 
Wbd 100 10 36 
WbdCft 58 13 65 
WbdCbd 24 10 48 
Enriched neutralizing 50 4 7 
antigen 
Summary of measures of the relative neutralizing activity of a platelet extract 
and fractions derived from it. Maximum neutralization for each fraction (i.e., 
the maximal percent neutralization that saturating concentrations of this 
fraction can produce, when assayed against Fab concentrations that inhibit 
50% of adhesion) was determined as in Fig. 3. This became the basis for 
further comparisons. The concentration of protein required to produce half 
maximum neutralization and the minimal concentration that produced max- 
imum neutralization is tabulated. 
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This interpretation is completely consistent with results 
obtained with a monoclonal antibody in the subsequent arti- 
cle (16). That antibody, although apparently directed against 
a single platelet glycoprotein, can totally inhibit platelet- 
collagen adhesion. Yet the antigen to which it is directed only 
partially neutralizes the polyclonal Fab used here, to a maxi- 
mal level of ~25% (16). This again suggests that several 
platelet entities participate in jplatelet-collagen adhesion, and 
that they are not independent. 
It remains possible that the multiple adhesion determinants 
discovered in this assay might represent protease fragments 
of a single adhesion molecule, each containing unique anti- 
genic sites. Octylglucoside xtraction of platelets may result 
in the release of proteases which could, despite phenylmeth- 
ylsulfonyl fluoride treatment, degrade adhesion molecules 
into smaller fragments. However, it would be necessary for 
the degradation to be complete, with no survival of the parent 
molecule, to lead to the results we found, which seems very 
unlikely. 
The subfraction W~C~ can be further resolved into two 
subfractions by PAGE in SDS. Again, the two subfractions 
resolved by this procedure appear to be antigenically distinct 
because ach is capable of neutralizing antibody only up to a 
maximum level that is considerably lower than that of the 
parent fraction. The smaller of the two active subfractions 
does not appear to be a degradation product of the larger 
active subfraction because, were this the case, the larger would 
be expected to be as effective a neutralizer as the starting 
material, WbaCf,. It is possible that both fractions are frag- 
ments of a single, even larger molecule which contains both 
groups of antigenic determinants. However, were this the 
case, one would have to conclude that the parent molecule 
was either completely degraded into these two fragments 
during fractionation, or was so large that it did not enter the 
polyacrylamide gel, because no active neutralizing material 
was found with Mr greater than ~130,000. It seems more 
likely that the two subfractions resolved by electrophoresis 
are distinct antigenic entities and possibly are distinct molec- 
ular entities, each playing a different but interdependent role 
in platelet-collagen adhesion, following reasoning like that 
detailed above. Whether the antigenically distinct entities 
represent distinct posttranslational modifications of one mol- 
ecule or fundamentally different molecules that play different 
roles in platelet-collagen adhesion cannot be determined from 
this analysis. The fact that N-CAM exists in different forms, 
based on posttranslational modifications (1) provides a prec- 
edent for this possibility. 
Given the apparent complexity of the system, we sought a 
way to separate the relevant components by first selectively 
purifying the crude antibody preparation and then using it to 
further purify the subfractions that had been resolved by 
lectin-affinity chromatography, This procedure gave rise to 
an active enriched neutralizing fraction that contained a 
relatively small number of protein bands, including a promi- 
nent protein with Mr - 125,000. This fraction could form the 
basis for further rounds of immunization and purification, 
following the "iterative approach" (1). An alternative was to 
turn to monoclonal antibodies to help resolve this complex 
situation. In the following article (16), we describe the utility 
of monoclonal antibodies in identifying one component of 
this adhesion mechanism. 
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